Home » Market News » DirectorsTalk Highlights » Doctors declare ‘golden age of treatment’ following breakthrough studies into a new immunotherapy drugs
Avacta Group Plc

Doctors declare ‘golden age of treatment’ following breakthrough studies into a new immunotherapy drugs

  • Oncologist Dr Harold Burstein said: ‘We are in a golden age of cancer treatment’  
  • Results on cancer drugs were shared at American Society For Clinical Oncology
  • Studies on immunotherapy drugs show patients living longer and healthier lives
  • Some pills, available on the NHS, have stopped tumour growth in cancer patients

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.